SinoMab Bioscience
Latest round
- Series C
Last raised
- Jan 2018
Total raised
- Undisclosed
Investors
- 1
About SinoMab Bioscience
Founded in 2001 and based in Hong Kong, SinoMab Bioscience Limited researches on, develops, manufactures, and markets immunotherapies for treating rheumatoid arthritis.
Who invested in SinoMab Bioscience
1 investor across 1 round
See all investors in SinoMab Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jan 1, 2018
Amount
Undisclosed
Investors
Questions about SinoMab Bioscience
Who invested in SinoMab Bioscience?
SinoMab Bioscience has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SinoMab Bioscience raised?
SinoMab Bioscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SinoMab Bioscience last raise money?
SinoMab Bioscience's most recent round on record is a Series C, in Jan 2018.
What does SinoMab Bioscience do?
Founded in 2001 and based in Hong Kong, SinoMab Bioscience Limited researches on, develops, manufactures, and markets immunotherapies for treating rheumatoid arthritis.
Where is SinoMab Bioscience headquartered?
SinoMab Bioscience is headquartered in Hong Kong, Hong Kong SAR - China.
Which VCs invest in companies like SinoMab Bioscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SinoMab Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like SinoMab Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.